Why Immunocal committed to improving women’s health in Nigeria, by Olagunju

On June 22, 2022, the World Health Organisation (WHO) called for menstrual health to be recognised and addressed as a health issue, not merely that of hygiene. Studies show that many women in Nigeria are suffering in silence from consequences of unhygienic practices.

Consequently, Immunotherapy Nigeria limited presented Immunocal – a bioactive biomolecules product that has contributed significantly to improving women’s health globally, most importantly in Nigeria. Immunotherapy Nigeria Limited, a commercial-stage company in partnership with Immunotec Inc., Canada, a biotechnology company introduced the product into Nigeria.

Immunocal, is a novel class of immunotherapy designed for supplying the molecules needed by the body to repair itself of a broad range of damaged cells, resulting in hormone balancing for men and women, improving menstrual health for women, controlling autoimmune conditions, and addressing resistant infectious diseases effectively, among many other benefits.

According to the manufacturers, “Women no longer need to suffer in silence.

“Immunocal is a specially formulated undenatured whey protein isolate with over 28 micro and macromolecules. Immunocal delivers these molecules into assists cells for maintaining optimal concentrations of the three most important biosynthesis in the body- neurotransmitters, catecholamines, and intracellular glutathione synthesis.”

Founder and CEO of Immunotherapy Nigeria Ltd, Lawrence Olagunju, said: “Immunocal is very powerful and it is the only product with the ability to influence simultaneously the three most important biosynthesis of health.”